Sphingolipid content of human adipose tissue: Relationship to adiponectin and insulin resistance

Obesity

Volumn 20, Issue 12, 2012, Pages 2341-2347

  Blachnio Zabielska, Agnieszka U ^a   Koutsari, Christina ^a   Tchkonia, Tamara ^a   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CERAMIDASE; ADIPONECTIN; CERAMIDE; GLUCOSE; INSULIN; INTERLEUKIN 6; NEUTRAL CERAMIDASE; SPHINGANINE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE;

ABDOMINAL FAT ASPIRATION BIOPSY; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FAT CONTENT; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; LIPID COMPOSITION; MALE; OBESITY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TISSUE LEVEL;

3T3-L1 CELLS; ADIPONECTIN; ADIPOSE TISSUE; ADULT; ANIMALS; CERAMIDES; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MICE; OBESITY; SPHINGOLIPIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870299468     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.126     Document Type: Article

References (40)

1. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
2. Lapidus L, Bengtsson C, Björntorp P. The quantitative relationship between "the metabolic syndrome" and abdominal obesity in women. Obes Res 1994;2:372-377.
3. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005;15:131-136.
4. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 2000;24 Suppl 4:S23-S27.
5. Verheij M, Bose R, Lin XH et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996;380:75-79.
6. Wang YM, Seibenhener ML, Vandenplas ML, Wooten MW. Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival. J Neurosci Res 1999;55:293-302.
7. Kolesnick R, Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene 2003;22:5897-5906.
8. MacRae VE, Burdon T, Ahmed SF, Farquharson C. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent. J Endocrinol 2006;191:369-377.
9. Oh HL, Seok JY, Kwon CH, Kang SK, Kim YK. Role of MAPK in ceramideinduced cell death in primary cultured astrocytes from mouse embryonic brain. Neurotoxicology 2006;27:31-38.
10. Ohanian J, Ohanian V. Sphingolipids in mammalian cell signalling. Cell Mol Life Sci 2001;58:2053-2068.
11. Adams JM 2nd , Pratipanawatr T, Berria R et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004;53:25-31.
12. Górski J, Dobrzyn A, Zendzian-Piotrowska M. The sphingomyelin-signaling pathway in skeletal muscles and its role in regulation of glucose uptake. Ann N Y Acad Sci 2002;967:236-248.
13. Straczkowski M, Kowalska I, Baranowski M et al. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 2007;50:2366-2373.
14. Straczkowski M, Kowalska I, Nikolajuk A et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004;53:1215-1221.
15. Turinsky J, O'Sullivan DM, Bayly BP. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 1990;265:16880-16885.
16. Chavez JA, Knotts TA, Wang LP et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003;278:10297-10303.
17. Chavez JA, Summers SA. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 2003;419:101-109.
18. Hajduch E, Balendran A, Batty IH et al. Ceramide impairs the insulindependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 2001;44:173-183.
19. JeBailey L, Wanono O, Niu W et al. Ceramide-and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes 2007;56:394-403.
20. Bonzón-Kulichenko E, Schwudke D, Gallardo N et al. Central leptin regulates total ceramide content and sterol regulatory element binding protein-1C proteolytic maturation in rat white adipose tissue. Endocrinology 2009;150:169-178.
21. Fernández-Veledo S, Hernandez R, Teruel T et al. Ceramide mediates TNF-alpha-induced insulin resistance on GLUT4 gene expression in brown adipocytes. Arch Physiol Biochem 2006;112:13-22.
22. Kolak M, Westerbacka J, Velagapudi VR et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56:1960-1968.
23. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006;55:2579-2587.
24. Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 1996;319 (Pt 1):179-184.
25. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991;266:21839-21845.
26. Stephens JM, Pekala PH. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. J Biol Chem 1992;267:13580-13584.
27. Shah C, Yang G, Lee I et al. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008;283:13538-13548.
28. Blachnio-Zabielska AU, Pulka M, Baranowski M et al. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue. J Cell Physiol 2012;227:550-557.
29. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr 1995;61:274-278.
30. Liu B, Hannun YA. Sphingomyelinase assay using radiolabeled substrate. Meth Enzymol 2000;311:164-167.
31. Nikolova-Karakashian M, Merrill AH Jr. Ceramidases. Meth Enzymol 2000;311:194-201.
32. Merrill AH Jr. Characterization of serine palmitoyltransferase activity in Chinese hamster ovary cells. Biochim Biophys Acta 1983;754:284-291.
33. Tchoukalova YD, Harteneck DA, Karwoski RA, Tarara J, Jensen MD. A quick, reliable, and automated method for fat cell sizing. J Lipid Res 2003;44:1795-1801.
34. Villa NY, Kupchak BR, Garitaonandia I et al. Sphingolipids function as downstream effectors of a fungal PAQR. Mol Pharmacol 2009;75:866-875.
35. Holland WL, Miller RA, Wang ZV et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011;17:55-63.
36. Wu D, Ren Z, Pae M et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 2007;179:4829-4839.
37. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119.
38. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
39. Haus JM, Kashyap SR, Kasumov T et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009;58:337-343.
40. Yang G, Badeanlou L, Bielawski J et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2009;297:E211-E224.